Venture Map · Round
Vaxdyn — Other · €14.5M
Announced 2024-09-04 · Sevilla · Biotech
The Seville-based vaccine biotech secured €14.5M from the European Commission's EIC Accelerator to take its multi-pathogen vaccine platform against antibiotic-resistant bacteria into the clinic. The package is blended finance: €2.5M in non-dilutive grant plus €12M in equity from the EIC Fund, awarded among 68 selected projects out of 969 applicants.
RoundOther
Amount€14.5M
LeadNot disclosed
Date2024-09-04
CitySevilla
SectorBiotech
